OCUL Competitors & Alternatives
Compare Ocular Therapeutix Inc with similar stocks in the same industry
Biotechnology
OCUL
Main Stock$6.66
Tradestie Score
59
Market Cap
$1.92B
Revenue Growth
-0.1%
Analyst Upside
+286.3%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$89.30
|
$1.55B | - | 26 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$34.22
|
$1.55B | 11.1 | 58 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$34.18
|
$1.55B | - | 37 | Compare |
|
NVAX
Novavax Inc
|
$9.98
|
$1.54B | - | 57 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.21
|
$1.50B | 7.1 | 51 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$20.95
|
$1.50B | - | 50 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$31.80
|
$1.49B | - | 43 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$18.80
|
$1.43B | - | 63 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$12.39
|
$1.42B | - | 51 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.59
|
$1.35B | - | 60 | Compare |
More OCUL Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry